Covid 19 Research using Clinical Trials (Home Page)
MultiStemWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (3)
Correlated MeSH Terms (1)
|
Name (Synonyms) |
Correlation |
D018352 | Coronavirus Infections NIH | 0.06 |
Correlated HPO Terms (0)
|
Name (Synonyms) |
Correlation |
There is one clinical trial.
Clinical Trials
Multicenter investigation featuring an open-label lead-in followed by a double blinded,
randomized, placebo-controlled Phase 2/3 part to evaluate the safety and efficacy of
MultiStem therapy in subjects with moderate to severe Acute Respiratory Distress Syndrome
(ARDS) due to COVID-19.
NCT04367077 ARDS Biological: MultiStem Biological: Placebo
Primary Outcomes
Measure: Ventilator-Free Days Time: Day 0 through Day 28.
Measure: Safety and Tolerability as measured by the incidence of treatment-emergent adverse events as assessed by CTCAE v5.0. Time: Day 28
Secondary Outcomes
Measure: All-cause mortality Time: Day 60
Measure: Ranked hierarchical composite outcome of alive and ventilator-free Time: Day 28
Measure: Ventilator-free days Time: Day 0 through Day 60
No related HPO nodes (Using clinical trials)